MedApp, an innovative medical-technology company listed on NewConnect, announces the expansion of its business into a new medical specialty – stomatology. The company, known for its advanced solutions in diagnostic imaging, is bringing 3D/4D technologies to dental offices, enabling doctors to use advanced tools during complex procedures.
As part of its new business segment, MedApp offers dentists advanced 3D/4D imaging technologies that can significantly improve the precision and efficiency of treatment. “In this particular case, we are counting more on foreign customers, although as I mentioned, this is a universal solution for all major dental clinics,” – says David Odrakiewicz, CEO of MedApp S.A.
One of the company’s key achievements is winning 510(k) Class II FDA certification for its CarnaLife Holo technology. This advanced technology enables augmented reality imaging of medical data through interactive holograms, which significantly supports the planning and execution of medical procedures. The FDA certification opens the door to partnerships with some of the largest medical-technology companies in the world and enables the technology to be offered to leading medical equipment manufacturers and hospitals in the US.
The United States is MedApp’s main foreign expansion market. The company plans to apply for another FDA certification by the end of 2024, which will allow it to expand the use of CarnaLife Holo to support intraoperative medical procedures.
MedApp is active in the U.S. market, where it established a subsidiary, MedApp USA Inc. in May 2024, in cooperation with partner Habeel Gazi.
MedApp – Empowergin people for better health.
